BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Roche (RHHBY) Seeks $6.8 Billion Win on Heart Pill Where Pfizer Inc. (PFE) Failed


8/19/2011 8:09:41 AM

Roche Holding AG (ROG) may get the first signs at a cardiology conference this month that the Swiss drugmaker can garner $6.8 billion in sales with a pill to combat heart disease by raising so-called good cholesterol. The drug, dalcetrapib, may reap that much in annual revenue by 2020 if it works in patients who have had heart attacks, estimates Gbola Amusa, a UBS AG analyst in London. He gives the pill a one-in-four chance of succeeding. That’s by no means a sure thing. Basel, Switzerland-based Roche, known for cancer medicines such as Avastin and Herceptin, is venturing into a new area. The basic concept was dealt a setback in May when a study found an Abbott Laboratories (ABT) drug to raise good cholesterol didn’t prevent heart attacks. Pfizer Inc. (PFE) had to scrap its version in 2006 after patients died.

Read at Bloomberg

Bloomberg
Roche
Pfizer Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES